ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ONVO Organovo Holdings Inc

1.00
0.0119 (1.20%)
Apr 26 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Organovo Holdings Inc ONVO NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.0119 1.20% 1.00 19:00:00
Open Price Low Price High Price Close Price Previous Close
0.9881 0.9801 1.0256 1.00 0.9881
more quote information »

Recent News

Date Time Source Heading
4/15/202407:05GLOBEOrganovo Announces Positive Phase 2 Results for FXR314 in..
2/08/202423:15EDGAR2Form EFFECT - Notice of Effectiveness
2/08/202415:56EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2/08/202415:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2/07/202407:05EDGAR2Form 8-K - Current report
1/26/202416:09EDGAR2Form S-3 - Registration statement under Securities Act of..
1/25/202407:05GLOBEOrganovo Presents FXR314 3D Human Tissue Model Findings That..
1/09/202407:05GLOBEOrganovo To Present FXR314 IBD 3D Model Findings at Upcoming..
12/28/202315:05EDGAR2Form 8-K - Current report
12/22/202305:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
12/06/202307:05GLOBEOrganovo Provides Timing for Release of FXR314 Phase 2 NASH..
12/01/202315:07EDGAR2Form S-8 - Securities to be offered to employees in employee..
11/17/202317:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/17/202317:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/17/202317:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/17/202317:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/17/202317:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/15/202315:41EDGAR2Form 144 - Report of proposed sale of securities
11/13/202307:05GLOBECORRECTION – Organovo Highlights FXR314 Combination Therapy..
11/09/202316:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/08/202307:05GLOBEOrganovo Highlights FXR314 Combination Therapy Potential and..
11/03/202307:05EDGAR2Form 8-K - Current report
9/22/202315:05EDGAR2Form 8-K/A - Current report: [Amend]
9/13/202316:06EDGAR2Form DEF 14A - Other definitive proxy statements
9/13/202316:06EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
9/12/202315:11EDGAR2Form 8-K - Current report
9/08/202311:46GLOBEOrganovo to Participate in the H.C. Wainwright Global..
9/05/202305:04EDGAR2Form 8-K - Current report
8/23/202307:05GLOBEOrganovo Advances Clinical Timelines for FXR314 and Provides..
8/22/202315:45EDGAR2Form 8-K - Current report
8/10/202315:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
7/31/202315:05EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
7/24/202315:27EDGAR2Form 8-K - Current report
7/14/202316:05EDGAR2Form PRE 14A - Other preliminary proxy statements
6/29/202315:06EDGAR2Form NT 10-K - Notification of inability to timely file Form..

Your Recent History

Delayed Upgrade Clock